Creating new proteins that help with important chemical reactions in the body
Designing Functional Metalloproteins
This study is all about creating new proteins that can help our cells work better by understanding how metal ions interact with them, which could lead to exciting improvements in biotechnology and medicine.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Michigan at Ann Arbor NIH-funded |
| Lab location | 1 site (Ann Arbor, United States) |
| Project ID | NIH-10755605 on NIH RePORTER |
What this research studies
This research focuses on designing metalloproteins, which are essential for various cellular functions such as energy generation and metabolism. By understanding how metal ions interact with protein structures, the researchers aim to create new proteins that can efficiently catalyze important chemical transformations. The approach involves synthesizing simple, water-soluble proteins that mimic natural metalloproteins, allowing for controlled studies of their catalytic properties. This could lead to advancements in biotechnology and medicine by improving our understanding of how these proteins function.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with metabolic disorders or conditions that could benefit from improved enzymatic functions.
Not a fit: Patients with conditions unrelated to metabolic processes or those who do not require enzymatic interventions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of new therapeutic proteins that enhance metabolic processes or improve drug efficacy.
How similar studies have performed: Other research has shown promise in designing synthetic proteins for catalytic purposes, indicating that this approach has potential for success.
Where this research is happening
Ann Arbor, United States
- University of Michigan at Ann Arbor — Ann Arbor, United States (Active)
Researchers
- Principal investigator: Pecoraro, Vincent L — University of Michigan at Ann Arbor
- Study coordinator: Pecoraro, Vincent L
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.